About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2118 blog entries.

Texas

Prior to the legislature adjourning its biennial regular session on May 31, the legislature approved two bills NACDS supported relating to the contractual relationship between a pharmacist or pharmacy and a Health Benefit Plan Issuer or Pharmacy Benefit Manager.

  • HB 1763 by Rep. Tom Oliverson (R) regulates the contractual relationships between a pharmacist or pharmacy and a health plan or PBM. NACDS supported the following provisions of H.B. 1763:
    • Provisions that helped ensure that Texas pharmacies may be fairly and properly reimbursed for the prescription medications they provide and associated pharmacy services such as preventive treatments, immunizations, and helping patients access and take their medications accurately and safely;
    • Provisions that required equal access to all network pharmacies and should help all Texans continue to receive care from the pharmacy of their choice;
    • Provisions that required the terms of pharmacy contracts be clearly defined, especially concerning drug pricing and prohibiting the claw back of pharmacy reimbursement after a claim has been adjudicated at the point of sale.

NACDS submitted a letter urging Gov. Greg Abbott (R)to sign the bill, which he did on May 26 with an effective date of September 1, 2021.

  • HB 1919 by Rep. Cody Harris (R) will help maintain patients’ right to choose a pharmacy provider by prohibiting health benefit plans and pharmacy benefit managers from “steering” or otherwise directing patients to use any particular in-network pharmacy provider over another. This bill helps ensure that patients are not penalized for choosing the pharmacy provider that best suits their individual needs. NACDS submitted a letter urging Gov. Abbott to sign the bill into law before the June 20th

Also in Texas, unfortunately, three bills NACDS supported died.

  • HB 678 by Rep. Phil Cortez (D) would have removed the existing administrative barriers requiring a prescription for influenza vaccines given to patients younger than 7 years of age and for any other vaccine given to patients younger than 14 years of age. This legislation proposed to align Texas requirements for vaccines given to younger people with the U.S. Department of Health and Human Services’ declaration under the Public Readiness and Emergency Preparedness Act that “authorizes state-licensed pharmacists to order and administer vaccines to individuals ages three through 18 years.” It passed the House by a vote of 139-7 but died in the Senate; and
  • HB 2049 by Rep. Donna Howard (D) would have allowed pharmacists to furnish medications according to the result of a positive Clinical Laboratory Improvement Amendments (CLIA)-waived test for acute conditions such as flu and strep throat passed the House Public Health Committee but failed to be set on the House Calendar.
  • HB 2346 by Stephanie Klick clarifying the law that stops the Health and Human Service Commission’s Vendor Drug Program (Medicaid) from proceeding with recent guidance to pharmacies to include discount card and membership program pricing in their calculations for Medicaid reimbursement rates died in the House Human Services Committee.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2021-06-04T12:56:23-04:00June 4, 2021|Texas|

Washington

The telemedicine rules workshop scheduled for June 4 was canceled. For more information about when it will be rescheduled, contact Amelia Boyd, Program Manager, at amelia.boyd@wmc.wa.gov.

Also in Washington, the Health Care Authority (HCA) issued a primary care stakeholder survey aimed at gathering provider and other stakeholder input on proposed provider accountabilities under the WA Multi-payer Primary Care Transformation Model. Feedback from this survey will be combined with payer input to build out an overall framework of accountabilities for both providers and payers under the Model.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2021-06-04T12:55:09-04:00June 4, 2021|Washington|

California

AB 1430, legislation requiring pharmacies to dispense Schedule II prescription drugs in lockable vials, was held on the Assembly Appropriations Suspense File and will not advance.

Also in California, the following bills failed the policy/legislative deadline and have become two-year bills.  They may not be acted upon until January 2022.

  • AB 458, legislation creating the Affordable Prescription Drug Importation Program in the California Health and Human Services Agency (CHHSA), under which the state would be a licensed wholesaler that imports prescription drugs for the exclusive purpose of dispensing those drugs to program participants upon federal approval for the importation program.
  • AB 933, legislation requiring an enrollee’s or insured’s defined cost-sharing for each prescription drug to be calculated at the point-of-sale based on a price that is reduced by an amount equal to 90% of all rebates received, or to be received, in connection with the dispensing or administration of the drug. It would also prohibit a health care service plan, health insurer, or a plan’s or insurer’s agents from publishing or otherwise revealing information regarding the actual amount of rebates the health care service plan or health insurer receives on a product-specific, manufacturer-specific, or pharmacy-specific basis.

Also in California, the Office of Administrative Law has approved the following proposals.  The amended and new regulations are effective July 1, 2021.

  • To amend sections 1711 and 1713, and add section 1715.1, in Article 2 of Division 17 of Title 16 of the California Code of Regulations, regarding Automated Drug Delivery Systems.
  • To amend section 1707 in Article 2 of Division 17 of Title 16 of the California Code of Regulations, regarding Waiver Requirements for Off-site Storage of Records.

Lastly in California, the Department of Health Care Services posted the User Administration Console (UAC) Registration Troubleshooting bulletin on the Medi-Cal Rx web portal.  Additionally, DHSC issued the Medi-Cal Rx User Administration Console (UAC) Application Role bulletin to prepare pharmacies and prescribers for the upcoming Medi-Cal Rx transition by providing information on the currently available applications and their functionalities within the Medi-Cal Rx Secured Provider Portal.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2021-05-28T09:57:07-04:00May 28, 2021|California|

Florida

The Florida Board of Pharmacy issued a proposed rule that would amend regulations under FAC 64B16-31 to update references to the incorporated application forms for pharmacy interns, consultant pharmacists, nuclear pharmacists, and pharmacy technicians. Comments and hearing requests are due June 14, 2021.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-05-28T09:53:58-04:00May 28, 2021|Florida|

Georgia

The Georgia Board of Pharmacy issued a final rule to amend regulations under GAC 480-10 to require a Class A balance with weights or electronic balance only if compounding on-site using components that must be weighed. The rule became effective May 10.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-05-28T09:53:14-04:00May 28, 2021|Georgia|

Iowa

The next meeting of the Iowa Board of Pharmacy’s IMP3 Committee meeting is scheduled for June 2, 2021. The information and agenda have been posted.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2021-05-28T09:52:09-04:00May 28, 2021|Iowa|

Oklahoma

In The Oklahoma Register Vol. 38 No. 17, the Oklahoma Health Care Authority published an emergency rule amending regulations under OAC 317:30-5 to revise provisions regarding diabetes self-management education and support providers to update requirements for Medicaid payment of providers and requirements that such providers be certified. The rule also allows registered dietitians, registered nurses, and pharmacists to render services and be reimbursed when meeting specific licensure, training, and experience requirements. The rule became effective April 14 and expires September 14, 2022.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2021-05-28T09:51:13-04:00May 28, 2021|Oklahoma|

Texas

On May 26, Gov. Abbott signed HB1763 into law which becomes effective September 1, 2021. NACDS applauds Gov. Abbott, Sen. Lois Kolkhorst (R), Rep. Tom Oliverson (R), Sen. Bryan Hughes (R), and Rep. Eddie Lucio III (D) for passing this important legislation and look forward to continued collaboration on these efforts that maintain patient access and creates long-term viable reimbursement models in the commercial market.  HB1763 is crucial for the continued viability of retail community pharmacies in Texas by creating PBM reform that prohibits harmful claw backs, requires that all pharmacies be fairly and properly reimbursed, and provides patients with equal access to all network pharmacies by allowing patients to receive care from the pharmacy of their choice.  In a letter of support, NACDS urged Gov. Abbott to sign HB1763 to maintain patient access and help ensure that local Texas pharmacies are properly reimbursed for the prescription medications they provide and associated pharmacy services.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2021-05-28T09:50:10-04:00May 28, 2021|Texas|

Virginia

The Board of Pharmacy has posted the agenda for the June 4 meeting. The BOP will be reviewing legislation passed by the General Assembly in the 2021 session including HB 2079 (initiation of treatment, dispensing of supplies and devices; HIV treatment; test & treat for CLIA-waived tests including flu and strep; tobacco cessation prescribing). A stakeholders’ workgroup will be convened to make recommendations on CLIA test and treat to the Joint Commission on Health Care due November 1, 2021. Additionally, there will be another workgroup tasked with making recommendations on expansion pharmacy technicians’ duties as a result of the passage of HB 1304 of 2020 with a report also due November. 1. Further detail is in the agenda packet.  NACDS and VACDS expect to participate in both stakeholder workgroups.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2021-05-28T09:49:16-04:00May 28, 2021|Virginia|
Go to Top